These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 26279399)

  • 21. Partial characterization and distribution of the chemokines CCL25 and CCL28 in the bovine system.
    Distelhorst K; Voyich J; Wilson E
    Vet Immunol Immunopathol; 2010 Nov; 138(1-2):134-8. PubMed ID: 20688401
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CCL25/CCR9 Signal Promotes Migration and Invasion in Hepatocellular and Breast Cancer Cell Lines.
    Zhang Z; Sun T; Chen Y; Gong S; Sun X; Zou F; Peng R
    DNA Cell Biol; 2016 Jul; 35(7):348-57. PubMed ID: 27008282
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CCR9 Promotes Migration and Invasion of Lung Adenocarcinoma Cancer Stem Cells.
    Lu L; Du H; Huang H; Wang C; Wang P; Zha Z; Wu Y; Liu X; Weng C; Fang X; Li B; Mao H; Wang L; Guan M; Liu G
    Int J Med Sci; 2020; 17(7):912-920. PubMed ID: 32308544
    [No Abstract]   [Full Text] [Related]  

  • 24. Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9
    Chen H; Cong X; Wu C; Wu X; Wang J; Mao K; Li J; Zhu G; Liu F; Meng X; Song J; Sun X; Wang X; Liu S; Zhang S; Yang X; Song Y; Yang YG; Sun T
    Sci Adv; 2020 Jan; 6(5):eaax4690. PubMed ID: 32064335
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemokine 25-induced signaling suppresses colon cancer invasion and metastasis.
    Chen HJ; Edwards R; Tucci S; Bu P; Milsom J; Lee S; Edelmann W; Gümüs ZH; Shen X; Lipkin S
    J Clin Invest; 2012 Sep; 122(9):3184-96. PubMed ID: 22863617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CCR9 mediates PI3K/AKT-dependent antiapoptotic signals in prostate cancer cells and inhibition of CCR9-CCL25 interaction enhances the cytotoxic effects of etoposide.
    Sharma PK; Singh R; Novakovic KR; Eaton JW; Grizzle WE; Singh S
    Int J Cancer; 2010 Nov; 127(9):2020-30. PubMed ID: 20127861
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The chemokine receptor CCR9 is required for the T-cell-mediated regulation of chronic ileitis in mice.
    Wermers JD; McNamee EN; Wurbel MA; Jedlicka P; Rivera-Nieves J
    Gastroenterology; 2011 May; 140(5):1526-35.e3. PubMed ID: 21300065
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CCL25/CCR9 interactions are not essential for colitis development but are required for innate immune cell protection from chronic experimental murine colitis.
    Wurbel MA; Le Bras S; Ibourk M; Pardo M; McIntire MG; Coco D; Geha RS; Fiebiger E; Snapper SB
    Inflamm Bowel Dis; 2014 Jul; 20(7):1165-76. PubMed ID: 24874458
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CCL25 chemokine-guided stem cell attraction: an assessment of possible benefits and risks.
    Spinnen J; Ringe J; Sittinger M
    Regen Med; 2018 Oct; 13(7):833-844. PubMed ID: 30284497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of the CCL25-CCR9 axis in beta-cell function: potential for therapeutic intervention in type 2 diabetes.
    Atanes P; Lee V; Huang GC; Persaud SJ
    Metabolism; 2020 Dec; 113():154394. PubMed ID: 33058852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CCR9 Antagonists in the Treatment of Ulcerative Colitis.
    Bekker P; Ebsworth K; Walters MJ; Berahovich RD; Ertl LS; Charvat TT; Punna S; Powers JP; Campbell JJ; Sullivan TJ; Jaen JC; Schall TJ
    Mediators Inflamm; 2015; 2015():628340. PubMed ID: 26457007
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CCR9/CCL25 expression in non-small cell lung cancer correlates with aggressive disease and mediates key steps of metastasis.
    Gupta P; Sharma PK; Mir H; Singh R; Singh N; Kloecker GH; Lillard JW; Singh S
    Oncotarget; 2014 Oct; 5(20):10170-9. PubMed ID: 25296976
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma.
    Hu J; Deng X; Bian X; Li G; Tong Y; Li Y; Wang Q; Xin R; He X; Zhou G; Xie P; Li Y; Wang JM; Cao Y
    Clin Cancer Res; 2005 Jul; 11(13):4658-65. PubMed ID: 16000558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CCL25 mediates migration, invasion and matrix metalloproteinase expression by breast cancer cells in a CCR9-dependent fashion.
    Johnson-Holiday C; Singh R; Johnson E; Singh S; Stockard CR; Grizzle WE; Lillard JW
    Int J Oncol; 2011 May; 38(5):1279-85. PubMed ID: 21344163
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC00853 restrains T cell acute lymphoblastic leukemia invasion and infiltration by regulating CCR9/CCL25.
    Li J; Muhammad J; Xie T; Sun J; Lei Y; Wei Z; Pan S; Qin H; Shao L; Jiang D; Zhang Q
    Mol Immunol; 2021 Dec; 140():267-275. PubMed ID: 34808497
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis.
    Rivera-Nieves J; Ho J; Bamias G; Ivashkina N; Ley K; Oppermann M; Cominelli F
    Gastroenterology; 2006 Nov; 131(5):1518-29. PubMed ID: 17101325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Commensal bacteria and expression of two major intestinal chemokines, TECK/CCL25 and MEC/CCL28, and their receptors.
    Meurens F; Berri M; Siggers RH; Willing BP; Salmon H; Van Kessel AG; Gerdts V
    PLoS One; 2007 Jul; 2(7):e677. PubMed ID: 17653288
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
    Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
    Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. miR-18a promotes malignant progression by impairing microRNA biogenesis in nasopharyngeal carcinoma.
    Luo Z; Dai Y; Zhang L; Jiang C; Li Z; Yang J; McCarthy JB; She X; Zhang W; Ma J; Xiong W; Wu M; Lu J; Li X; Li X; Xiang J; Li G
    Carcinogenesis; 2013 Feb; 34(2):415-25. PubMed ID: 23097559
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma.
    Jiang Q; Mai C; Yang H; Wu Q; Hua S; Yan C; Long Y; Zhang Y; Long X; Fang W; Liu Z
    Histopathology; 2014 Apr; 64(5):722-30. PubMed ID: 24168228
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.